Microbix strikes deal for major new Chinese vaccine joint venture
28 October 2009
Ian Haydock
Please Login to read the full article.
28 October 2009
Ian Haydock
ian.haydock@informa.com
Microbix Biosystems has signed an agreement with a state-owned Chinese pharmaceutical enterprise to set up a joint venture in China for the production of seasonal and pandemic flu vaccines.
The Canadian company said the deal would create the largest flu vaccine production facility in Asia...
Please Login to read the full article.
RELATED CONTENT
NEWS
- BARDA bestows $215 million flu vaccine contract on Novavax, VaxInnate
- Zydus to back Microbix's urokinase relaunch plans in North America
- VaxInnate strikes major Asian licensing deal for novel vaccine technology
- Asia Beat: Choppy waters on the horizon for Yellow Sea biocluster initiative
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
